Race to Develop Universal ‘Variant-Proof’ Covid Vaccine Involves Several Players

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – March 24, 2022 – USA News Group  –  Whenever a new COVID-19 variant emergences, health authorities have had limited options to fight back with other than more restrictions or boosters of authorized shots such as those from Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) […]

SPYR Technologies’ Applied Magix Introduces Limited Time Special Pricing and Expands Airing Schedule of Its Successful MagixDrive Commercial

The Woodlands, TX – March 24, 2022 – SPYR, Inc. (OTCQB: SPYR), dba SPYR Technologies (https://spyr.com/) (“SPYR” or the “Company”), a technology company whose subsidiary, Applied Magix, Inc., develops and resells Apple® ecosystem compatible products in the growing multibillion-dollar IoT smart home and connected car markets, introduces Limited Time Special Pricing of $99.99 for MagixDrive (stand-alone) […]

Oncolytics Biotech® Partner Adlai Nortye Advances Chinese Bridging Trial of Pelareorep-Paclitaxel Combination Treatment in Breast Cancer to Final Dosing Cohort

First two cohorts indicate pelareorep in combination with paclitaxel was well-tolerated with no new safety signals observed to date   Trial is designed to satisfy regulatory requirements and accelerate pelareorep’s development in large and rapidly growing pharmaceutical markets, including China, Hong Kong, Macau, Taiwan, Singapore, and South Korea   Final cohort’s dosing regimen is equivalent […]